Trial

A Prospective, Randomized, Open, Active-controlled, Interventional, Exploratory, Phase II Trial to Evaluate the EBA, Safety and PK of Orally Administered LCB01-0371 in Adult Patients With Smear-positive Pulmonary Tuberculosis

Study Director
T.S. Sim, M.D., Ph.D
Start Date
6 / 2017
Trial Phase
Phase II
Trial Status
enrolling
Current Enrollment
11 June 9, 2017
Target Enrollment
64
Overview
Developer Associations
Compound Associations